Noventra Pharma Tirzepatide Research Compound peptide Pen 60mg
Weight Management • Appetite Control • Metabolic Support
Noventra Pharma Tirzepatide 60mg is a compounded peptide pen designed for precision dosing and advanced research applications. This pre-filled pen system is engineered for consistency, stability, and controlled delivery, offering a convenient format for structured laboratory and metabolic research environments.
Tirzepatide is widely associated with dual GLP-1 and GIP receptor agonist activity and is commonly studied in relation to metabolic pathways, glucose regulation, appetite control, and energy balance mechanisms. The 60mg pen format supports extended research protocols requiring reliable and repeatable dosing.
Key Benefits
- Dual GLP-1 and GIP receptor agonist commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in weight management and glucose metabolism research contexts
- High-dose 60mg pen format for extended or large-scale research protocols
- Pre-filled pen system designed for convenience and dosing accuracy
- Supports consistent, controlled, and repeatable delivery in research use
- Long-acting peptide profile suitable for sustained research applications
- Stable compounded formulation designed for reliability and handling ease
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
